Heidi, a rapidly expanding healthcare AI company, has announced the establishment of its regional headquarters in Singapore, following a US$65m Series B funding round led by Point72 Private Investments. The company plans to invest US$8m over the next two to three years, aiming to hire 10–12 roles initially, with further expansion anticipated as the business grows.
The move comes as Singapore grapples with an ageing population and a shortage of clinicians, with projections indicating that by 2030, one in four Singaporeans will be aged 65 or older. Heidi’s AI platform, which transcribes doctor-patient conversations into structured clinical notes, is designed to increase clinicians’ effective capacity, allowing them more time for patient care. The platform has already supported nearly 55,000 consultations in Singapore.
“For Heidi, Singapore represents more than a market entry, it’s a launchpad for the next phase of healthcare innovation and growth across Southeast Asia,” said Dr Thomas Kelly, CEO and co-founder of Heidi. He highlighted Singapore’s supportive ecosystem and initiatives like the TRUST platform as key factors in accelerating AI adoption in healthcare.
Heidi’s Singapore launch is part of its broader global expansion, including recent moves into Hong Kong. The company’s AI tools currently process over 2 million patient consultations weekly across 116 countries. With this latest funding, Heidi’s total capital raised stands at US$96.6m, supported by investors such as Blackbird Ventures and LocalGlobe.
